Home » Newsletters » BioWorld Science

BioWorld Science

July 31, 2013

View Archived Issues

Roche presents highlights of second quarter 2013

Kalydeco beneficial in patients with cystic fibrosis and non-G551D gating mutations

EMA's CHMP issues positive opinion regarding afatinib

FDA lifts clinical hold on Cangene's recombinant factor IX product candidate

FDA grants orphan drug status to Convergence Pharmaceuticals' CNV-1014802

Depomed acquires Lazanda nasal spray

Anacor Pharmaceuticals submits NDA to the FDA for tavaborole

Kolltan in-licenses antibody targeting HER3

AbbVie reports key pipeline events of second quarter 2013

FDA accepts tasimelteon NDA for priority review

Noxxon Pharma patents new nucleic acid molecules

MK-8931 leads to reductions in brain amyloid levels in patients with Alzheimer's disease

Researchers at Nippon Chemiphar present novel P2X4 receptor antagonists

Acetylon Pharmaceuticals and Celgene to advance several HDAC inhibitors

Ref Pharma presents new agents for HCV infection

Scientists at ACEA Biosciences divulge new agents for cancer

Wellcome Trust grants award to GlycoVaxyn for Shigella program

Clinical evaluation of a novel prophylactic therapy for patients with hemophilia B

FDA grants priority review to NDA for MNK-795

U.S. university researchers patent new M1 receptor modulators

Evaluation of a glycoPEGylated recombinant coagulation factor for the treatment of hemophilia

BIND Therapeutics begins dosing in phase II trial in NSCLC

The development of a novel mouse model for Pick's disease

Perrigo enters definitive agreement to acquire Elan

European Commission grants orphan drug designation to BrainStorm's cell therapy for ALS

Novartis receives positive CHMP opinion for Ilaris in systemic juvenile idiopathic arthritis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...